Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.12.1 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.260EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.260EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.456EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.456EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.16 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.4.16 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20407.1China
B.1.1.449EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.449EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.152EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.152EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.146EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.146EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
D.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
D.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.81EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.81EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.89EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.89EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
M.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
M.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.333EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.333EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.429EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.429EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AN.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AN.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.221.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.221.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.242EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.242EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used